DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00809302 (ClinicalTrials.gov)	December 2008	15/12/2008	Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease	A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Doses of Aplindore MR (1, 3, and 6 mg Twice Daily) in Patients With Early Parkinson Disease (APLIED)	Early Parkinson Disease	Drug: aplindore MR tablets or Placebo	Neurogen Corporation	NULL	Terminated	30 Years	N/A	Both	9	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00809302
(ClinicalTrials.gov)

December 2008

15/12/2008

Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Doses of Aplindore MR (1, 3, and 6 mg Twice Daily) in Patients With Early Parkinson Disease (APLIED)

Early Parkinson Disease

Drug: aplindore MR tablets or Placebo

Neurogen Corporation

NULL

Terminated

30 Years

N/A

Both

Phase 2

United States